1
180therapeutics
180 Therapeutics develops novel biologic therapies, specifically anti-TNF therapeutics, to treat fibrosis. Their research focuses on understanding the mechanisms of scarring and fibrosis in human disease tissues, primarily targeting fibrosis in the liver, lung, and musculoskeletal system.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- 180 Therapeutics develops novel biologic therapies, specifically anti-TNF therapeutics, to treat fibrosis. Their research focuses on understanding the mechanisms of scarring and fibrosis in human disease tissues, primarily targeting fibrosis in the liver, lung, and musculoskeletal system.